Victory RS Science and Technology Y holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Victory RS Science and Technology Fund Class Y RIFYX
- NAV / 1-Day Return 40.95 / +0.52 %
- Total Assets 241.0M
-
Adj. Expense Ratio
1.240%
- Expense Ratio 1.240%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Technology
- Investment Style Large Growth
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.00
- Turnover 29%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 12:15 AM GMT+0
Morningstar’s Analysis RIFYX
Will RIFYX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the RIFYX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of RIFYX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 46.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
NVIDIA Corp | 10.22 | 19M | Technology |
Microsoft Corp | 6.74 | 13M | Technology |
Meta Platforms Inc Class A | 5.95 | 11M | Communication Services |
Amazon.com Inc | 4.40 | 8M | Consumer Cyclical |
AppLovin Corp Ordinary Shares - Class A | 3.97 | 7M | Communication Services |
MACOM Technology Solutions Holdings Inc | 3.94 | 7M | Technology |
Monolithic Power Systems Inc | 2.96 | 6M | Technology |
Coherent Corp | 2.87 | 5M | Technology |
Guardant Health Inc | 2.82 | 5M | Healthcare |
Netflix Inc | 2.80 | 5M | Communication Services |
United States